Astronics (ATROB) Cash & Equivalents (2010 - 2026)

Astronics (ATROB) has 17 years of Cash & Equivalents data on file, last reported at $11.9 million in Q2 2026.

• Cash & Equivalents for Q2 2026 came in at $11.9 million, down 52.16% year-over-year; the trailing twelve-month figure through Apr 2026 was $11.9 million (down 52.16% YoY), and the FY2025 annual result was $18.2 million, up 95.8% from the prior year.
• Cash & Equivalents eased to $11.9 million in Q2 2026 per ATROB's latest filing, from $18.2 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $24.8 million in Q1 2025 and troughed at $2.6 million in Q4 2022.
• A 5-year average of $10.1 million and a median of $9.3 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents sank 91.17% in 2022, then jumped 371.12% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $13.8 million in 2022, then plunged by 65.48% to $4.8 million in 2023, then surged by 95.23% to $9.3 million in 2024, then soared by 95.8% to $18.2 million in 2025, then sank by 34.72% to $11.9 million in 2026.
• Business Quant data shows ATROB's Cash & Equivalents at $11.9 million in Q2 2026, $18.2 million in Q4 2025, and $13.5 million in Q3 2025.